MJBizDaily
FDA approved cannabis: Why Schedule 3 means operators must prepare for pharmaceutical-grade MMJ now
Featured
Latest Posts
Missouri cannabis sales hit record $135.1 million in May
The average price of cannabis items sold dropped from $28.79 in May 2025 to $26.61 for the same month this year.
News June 10
Cannabis legislation could break Virginia’s budget impasse
Gov. Abigail Spanberger could support folding a regulated adult-use retail framework into the budget after vetoing a standalone sales bill.
News June 9
New Mexico built a successful cannabis market without the hype
New Mexico’s cannabis market is growing. It’s not flashy or headline-grabbing; it’s a steady climb to statewide success.
News June 9
Trulieve to become first US cannabis company listed on NYSE
Trulieve completed a corporate restructuring and that deconsolidated its operations in markets serving both medical and adult-use customers.
News June 8
Will rescheduling revive medical cannabis? It depends on the state
The opportunity is not just tax relief or capital access – it’s rebuilding cannabis around wellness and products tailored to specific needs.
News June 8
Michigan’s cannabis tax gamble comes up short in first quarter
The tax, which kicked in Jan. 1, was at the center of a bipartisan road-funding deal that ended a drawn-out budget standoff last year.
News June 5
DEA registration is a tough choice for medical marijuana operators
Registration provides a safe harbor for medical marijuana businesses, but they must hand over a lot of sensitive information to the agency.
News June 5
Alabama cannabis market opens with one dispensary, 11 to follow
To access the program, patients need a qualifying condition and a recommendation from a physician registered with the Alabama Medical Cannabis Commission.
News June 4
Cannabis’ challenge isn’t regulation – it’s enforcement
Ripple CEO Justin Singer says the real issue in the legal market is not too much regulation but too little enforcement.
News June 4
Latest Sponsored
